Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of design and implementation decisions in database studies.|
|Full bibliographic reference||Wang SV, Schneeweiss S, Berger ML, Brown J, de Vries F, Douglas I, Gagne JJ, Gini R, Klungel O, Mullins CD, Nguyen MD, Rassen JA, Smeeth L, Sturkenboom M; joint ISPE‐ISPOR Special Task Force on Real World Evidence in Health Care Decision Making. Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.
This guideline was published simultaneously in 2 journals. You can read the guideline in either of these journals using the links below.
Value Health. 2017;20(8):1009-1022. PMID: 28964431
Pharmacoepidemiol Drug Saf. 2017;26(9):1018-1032. PMID: 28913963
|Study design||Observational studies|
|Applies to the whole report or to individual sections of the report?||Data, Procedure/Method, Terminology/definitions|
|Record last updated on||November 23, 2021|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.
For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.
Visit our Help page for information about searching for reporting guidelines and for general information about using our website.